Related Experiment Video
Updated: Apr 15, 2026

06:43
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
12.9K
Autophagy in Alzheimer's disease
Reviews in the Neurosciences
|April 15, 2015
Summary
Autophagy, a vital cellular process for protein cleanup, is crucial for neuron survival. Impaired autophagy contributes significantly to neurodegenerative diseases like Alzheimer's disease (AD).
Area of Science:
- Cellular Biology
- Neuroscience
- Molecular Biology
Background:
- Autophagy is a fundamental cellular degradation pathway essential for maintaining protein homeostasis and cell health.
- Neurons exhibit a high dependence on basal autophagy for survival, more so than non-neuronal cells.
- Defects in autophagy are increasingly implicated in the pathogenesis of neurodegenerative diseases, notably Alzheimer's disease (AD).
Purpose of the Study:
- To review recent research highlighting the role of autophagy deficits in Alzheimer's disease.
- To consolidate evidence supporting the contribution of impaired autophagy to AD etiology.
- To emphasize the significance of autophagy-lysosome pathway dysfunction in early AD pathogenesis.
Main Methods:
- Literature review of recent studies on autophagy and Alzheimer's disease.
- Analysis of research focusing on the link between autophagy deficits and neurodegeneration.
- Synthesis of findings related to the early stages of AD pathogenesis and autophagy-lysosome defects.
Main Results:
- Autophagy-lysosome defects are observed early in the pathological process of Alzheimer's disease.
- Impaired autophagy is a significant factor contributing to the progression of Alzheimer's disease.
- Recent studies provide substantial evidence supporting the role of autophagy deficits in AD.
Conclusions:
- Autophagy deficits are strongly linked to the development and progression of Alzheimer's disease.
- The autophagy-lysosome pathway is a critical area of focus for understanding and potentially treating AD.
- Further research into autophagy mechanisms in AD is warranted to explore therapeutic strategies.
Related Concept Videos
Autophagy
6.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.2K
Delivery Pathways to the Lysosome
10.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.6K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Autophagic Cell Death
5.1K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.1K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Lysosomal Hydrolases
4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K

